Delivery Order SPE2DB22D2006-SPE2DB25FW2UE
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $16,551.16, represents a non-competitive set-aside award and is scheduled for completion by August 19, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,006.19 and an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for Metadate CD Caps 20mg with a ceiling value of $6,285.14. This firm fixed price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The product will be delivered to the contractor's facility in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Metadate CD Caps 20mg, a prescription medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $5,961.67, represents a non-set-aside competitive award and is scheduled for completion by July 31, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Metadate CD Caps 10mg, a methylphenidate-based medication used in the treatment of attention deficit hyperactivity disorder. The contract, valued at $3,183.82 with a firm fixed price structure, was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,086.87 for Metadate CD Caps 50mg under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The contract, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a competitively awarded procurement with no set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Department of Defense's Medical Supply Chain awarded a $2,278.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 20mg on July 21, 2025, with completion targeted for July 22, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, which carries a $999,999,999.00 ceiling and extends through December 2026. The...
- This is a $9,315.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for METADATE CD CAPS 20MG. The contract is not set-aside and has an ultimate completion date of July 8, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026....
- On July 18, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,295.31 to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of July 21, 2025. The contract is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Metadate CD 30mg tablets, valued at $9,277.04. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2UEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Metadate CD 20 mg capsules (30-count supply) with a ceiling value of $1,588.92. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and medical devices across multiple therapeutic domains. This particular delivery order for Metadate CD, a controlled-release methylphenidate product used for attention deficit hyperactivity disorder treatment, represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare systems' ongoing medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/24/25 |